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Long-term cognitive impairment and delirium in intensive 
care: a prospective cohort study 
 
ABSTRACT 
Background: Whilst there is a growing body of research exploring the effect of 
delirium in intensive care unit (ICU) patients, the relationship between patient 
delirium and long-term cognitive impairment has not been investigated in settings 
where low rates of delirium have been reported.   
Objectives: To assess the association between the incidence of delirium, duration of 
mechanical ventilation and long term cognitive impairment in general ICU patients. 
Methods: Prospective cohort study conducted in a tertiary level ICU in Queensland, 
Australia. Adult medical and surgical ICU patients receiving ≥12 hours’ mechanical 
ventilation were assessed for delirium on at least one day. Cognitive impairment was 
assessed at three and/or six-months using the: Repeatable Battery for the Assessment 
of Neuropsychological Status (RBANS); Trail Making Test (TMT) Part A and B; and 
Mini-Mental State Examination (MMSE).  
Results: Of 148 enrollees, 91 (61%) completed assessment at three and/or six months. 
Incidence of delirium was 19%, with 41% cognitively impaired at three months and 
24% remaining impaired at six months. Delirium was associated with impaired 
cognition at six-months: mean TMT Part A scores (information processing speed) 
were 7.86 seconds longer than those with no delirium (p=0.03), and mean TMT Part 
B scores (executive functioning) 24.0 seconds longer (p=0.04). 
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Conclusions: ICU delirium was positively associated with impaired information 
processing speed and executive functioning at six-months post-discharge for this 
cohort. Testing for cognitive impairment with RBANS and TMT should be 
considered due to its greater sensitivity in comparison to the MMSE.  
 
Introduction 
Delirium is a common neuropsychiatric syndrome that, although occurring in a range 
of healthcare settings, is particularly prevalent in hospitalized intensive care unit 
(ICU) patients. However, the incidence of ICU delirium varies widely worldwide – 23 
to 84% in North America; 1-4 15% to 39% in Europe; 5, 6  63% in Asia 6; and 12% to 
45% in Australia.6, 7 Reasons for these disparities include differences in the severity of 
illness of ICU patients between countries,3 methodological differences in research, the 
fluctuating nature of delirium and the inability of clinicians to detect delirium.8 
Models of care differ in relation to sedation and mobilization practices which affect 
rates of delirium in ICU patients.1 
Delirium in the ICU patient has been associated with various risk factors 
including patient age;6 excessive alcohol consumption;6 psychoactive medications 
including benzodiazepines and opioids;9 mechanical ventilation;10 coma; infection; 
metabolic acidosis and severity of illness.6 Adverse patient outcomes, both during 
hospitalization and in the longer-term, post-discharge are also reported.11-18 These 
include prolonged mechanical ventilation;15 increased ICU and hospital length of stay 
(LOS);15 increased risk of in-hospital falls;16  increased risk of post-traumatic stress 
symptoms;12 reduced quality of life post-discharge;11 increased risk of newly acquired 
functional disability in activities of daily living post-discharge;2 and increased 
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mortality rates. 11  In addition, patients are also at an increased risk of cognitive 
impairments months to years after ICU.19 Whilst improvements in cognitive function 
typically occur in the first year post ICU discharge,20 between a quarter and half of  
ICU survivors report persistent impairment at one,3, 4 two,21 and six years.22 Both 
longer duration of delirium4, 5 and, more recently, greater severity of delirium,23 have 
been identified as risk factors of cognitive impairment. Analgesics and sedative 
medications have also been posited as possible mechanisms through which both 
delirium and cognitive impairment develops, 19 although findings to date remain 
mixed.4, 24 
Whilst there is a growing body of research exploring the effect of delirium in 
ICU patients, the relationship between patient delirium and cognitive impairment has 
limited reports of investigation in settings where low rates of delirium have been 
reported.6, 11, 17, 18 Consequently, the current study sought to explore the association 
between the incidence of delirium, duration of mechanical ventilation and patients’ 
cognition at three and six-months post ICU discharge. To aid international 
comparison, the study design was based on that conducted in the USA by Girard et 
al,3 which was the first prospective cohort study to identify delirium as a predictor of 
long-term cognitive impairment at three and 12-months post-discharge All risk 
factors, covariates and outcomes were determined a priori and based on Girard et al’s 
work.3 However, limitations of Girard et al’s study included the exclusion of  surgical 
patients, and the study being nested within a sedation and weaning protocol clinical 
trial3 which may have had some inadvertent impact on the results.    
 
Methods 
Study Design, Sample, and Setting 
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This prospective cohort study was conducted in the ICU at a tertiary referral teaching 
hospital in Australia. The 750-bed hospital has a 25-bed ICU with approximately 
2,200 adult surgical, medical and trauma patients admitted yearly.  
ICU nurses with advanced knowledge and previous training in all aspects of 
research including screening, data collection and data entry worked as research nurses 
for the project. They screened ICU patients daily for inclusion, with those aged ≥18 
years and mechanically ventilated for ≥12 hours eligible. Patients were excluded if 
they: were not receiving active ICU treatment as determined in discussion with the 
ICU consultant (i.e., palliative care); were unable to communicate in English; were 
likely to be inaccessible in-person (i.e., geographically) for follow-up; had a pre-
existing neurological deficit that prevented independent living; 3 or had a traumatic 
brain injury with a Glasgow Coma Scale24 score <14. 
Ethical approval for the study was granted by the relevant Human Research 
Ethics Committees (HREC/11/QPAH/230; NRS 34/11/HREC). Ethical principles 
stated in the Declaration of Helsinki and the National Statement on Ethical Conduct in 
Research Involving Humans were adhered to. Patient’s next of kin provided written 
informed consent at study enrolment, with subsequent written consent obtained from 
the patient prior to discharge and confirmed before subsequent assessments. 
 
Risk Factors, Covariates, and Outcomes 
Risk Factors: The primary predictor was the number of delirium days the patient 
experienced in the ICU. Duration of delirium was defined as the number of days, to a 
maximum of 28, participants were assessed as positive using the Confusion 
Assessment Method for the ICU (CAM-ICU)(25) at least once each day. Participants 
assessed as having a Richmond Agitation-Sedation Scale (RASS) 26 score of -4 or -5 
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(i.e. deeply sedated) were not assessed for delirium in line with instructions for use of 
the CAM-ICU. 25 Both the RASS and CAM-ICU are routinely used in the study ICU. 
A secondary predictor variable was the duration of mechanical ventilation 
(defined as the time from endotracheal intubation to successful extubation and 
unassisted ventilation). In keeping with Girard et al,3 duration of mechanical 
ventilation was included to explore the possibility that it was a predictor of cognitive 
impairment. 12, 27 
Covariates: Covariates included: age; sex; highest level of education; admission 
diagnosis; severity of illness (Acute Physiology and Chronic Health Evaluation II and 
III scores [APACHE II & III])28, 29; ICU LOS; hospital LOS; total doses administered 
in ICU of propofol, benzodiazepines (milligram [mg] of lorazepam equivalent using 
the following conversion formulas: 1 mg of lorazepam equals: 0.5mg of alprazolam; 
5mg of diazepam; 2.5mg of midazolam; 15mg of oxazepam; and 15mg of temazepam 
[personal email correspondence with Girard TD, 11th September 2014]), and opioids 
(mg of fentanyl equivalent using the following conversion formulas: 1 mg of fentanyl 
equals 70mg of methadone; 66.7mg of morphine; 10mg of oxycodone; and 0.83mg of 
remifentanyl).  
Outcomes: The primary outcome was participants’ cognitive status at three and six-
months post ICU discharge. Cognitive assessment was conducted by trained 
psychologists blinded to the details of each participant’s critical illness and number of 
delirium days. Assessment was undertaken face-to-face at the participant’s home, the 
hospital, or the university’s Psychology Clinic. Three validated measures were used to 
assess participant’s cognition: 
1) The Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS)30 profiles cognitive impairment across five domains that are each 
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comprised of sub-tests that provide raw scores, adjusted for age, to give a 
standardized index score for domain and an overall score (mean 100; SD=15). Lower 
scores indicate worse cognitive functioning. RBANS has demonstrated reliability and 
validity in various contexts and countries,30, 31 and Australian normative data are 
available. 31 In this study, participant’s  scores were categorized as: no cognitive 
impairment; mild-moderate cognitive impairment; severe cognitive impairment based 
on their standardized index scores using the procedures found in Girard et al’s study.3  
That is, participants were classified as mildly to moderately impaired if they scored 
1.5 SD below the mean on two of the index scores or 2 SD below the mean on one of 
the index scores. They were classified as severely impaired if they scored 1.5 SD 
below the mean on three or more of the index scores or 2 SD below the mean on two 
or more of the index scores. Participants who scored higher than 1.5 SD of the means 
on four or five of the index scores were classified as having no impairment.  
2) Trail Making Test (TMT)32 is comprised of two parts, both of which are timed tests 
and focus on sequential responses. Part A measures information processing speed, 
whilst Part B provides an index of executive functioning. The two parts are scored 
and reported separately. The participant’s performance metric is the time taken to 
complete the tests. TMT has been used in a variety of settings, and Australian 
normative data is available.33 In this study, a TMT_Part A completion time of ≥40 
seconds indicated impaired information processing speed, and a TMT_Part B 
completion time of ≥92 seconds indicated impaired executive functioning.32 
3) The Mini-Mental State Examination (MMSE)(34) is a commonly used global 
cognitive assessment in older adults and can be used to measure cognitive changes 
over time. Scores range from 0-30, with lower scores indicative of greater cognitive 
impairment. In this study, a score of ≤26 indicated cognitive impairment, with scores 
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of 27-30 indicating normal cognitive functioning. A higher than usual cutoff of 26 
was adopted because MMSE scores have been found to be related to years of 
education and lower cutoff scores may incorrectly misclassify someone who is 
cognitively impaired, but able to compensate for performance because of higher 
educational level. A higher cutoff is considered appropriate for screening purpose 
when sensitivity should be emphasized over specificity.35  
 
Data Analysis 
To explore whether duration of delirium or days of mechanical ventilation 
predicted long-term cognitive impairment at three and six-months post-discharge, a 
series of linear regressions were undertaken for the three outcome measures (RBANS; 
TMT_Part A; TMT_Part B; and MMSE), adjusting for possible covariates (age; sex; 
highest level of education; ICU LOS; APACHE II; APACHE III; and total dose of 
Propofol, Benzodiazepine, and Opioids in ICU). Variables with p<0.2 in univariate 
analysis were entered into multivariate models with the exception of age and 
education, which were entered in all models regardless of significance due to known 
associations with the outcomes. Multivariate models were constructed using a manual 
backward (at p<0.05) model building technique. Correlation between covariates and 
model assumptions (distribution of the residuals, influential observations) were 
checked. Regarding the MMSE outcome, it was not possible to fit a regression model 
due to the low number (below or near 10 cases per independent variable) of 
participants who were classified as cognitively impaired with this outcome. Thus, 
regression model results are only presented for the RBANS (total score after adjusting 
for age, remaining in natural scale) and TMT_Part A and Part_B (transformed to 
approximately normal distributions using the formula: inverse square root of time, (in 
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seconds)).  Regarding the covariates, age was centered around the mean for easier 
interpretation, whilst sex, ICU LOS, APACHE II, and APACHE III were entered into 
regression models in their natural scale.36 Education was recoded into three categories 
(secondary education or less; certificate/diploma; and university). The variables 
indicating propofol, benzodiazepine and opiates doses were coded into ordinal 
variables with six approximately balanced groups (analysis was repeated with 
propofol, benzodiazepine and opiates doses expressed as average daily values). 
Delirium was expressed in days, and defined as at least one positive delirium 
assessment made in the day using the CAM-ICU. In the study by Girard et al,3 
delirium was analyzed as a continuous variable; however, few patients experienced ≥2 
days of delirium in our current study (7%) and, for statistical integrity, delirium was 
analyzed as a dichotomous variable. 
The effect of multiple comparisons was considered when evaluating the 
results. Statistical significance was declared at p<0.05. All data analyses were 
performed using STATA version 12.1 (StataCorp, Texas, USA). 
Results 
During the recruitment period, 421 patients met the eligibility criteria and 148 
participants were enrolled into the study between November 2011 and the end of 
2014. Ninety-one (61%) participants completed an outcome measure assessment at 
either one or both time points: 88 were successfully assessed at three months, 79 at six 
months, and 76 were tested at both time points (Figure 1). 
 
Sample Characteristics 
Most of the study participants were males, aged 43 - 65 years, with varied educational 
backgrounds (Table 1), and a mean severity of illness (APACHE II) score of 18. 
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Participants’ length of ICU stay was 4.3 days and they were mechanically ventilated 
for 2.2 days. The incidence of ICU delirium was 19%, and just 7% of participants 
experienced delirium on multiple days. 
There was no difference in the characteristics of the 91 study participants who 
completed at least one cognitive test when compared with the 57 participants enrolled 
but not tested at either the three or six-month time points (due to withdrawal, loss to 
follow-up or deceased), and the incidence of delirium was comparable (17% for those 
tested vs. 14% for those not tested at either time points, results not presented). 
 
Cognitive Impairment at Three and Six Months Follow-Up 
Using the RBANS, cognitive impairment remained for 36 (41%) participants at three-
months, and 19 (24%) at six-months post ICU discharge (Table 2). Similar patterns 
were observed for the TMT_Parts A and B, with the frequency of impairment 
reducing over time but persisting in more than a quarter of participants. Using the 
MMSE, there was a slight increase in the number of participants assessed as 
cognitively impaired from three to six months (n=2 vs. n=4). 
When considering only the 76 participants who were tested at both time 
points, 27 (36%) participants had cognitive impairment on the RBANS at three-
months, and 17 (22%) participants remained impaired when tested at six- months post 
ICU discharge. Using the TMT_Part A, 20 (30%) participants had impaired 
information processing speed at three-months, with 16 (24%) participants remaining 
impaired when tested at six- months. Similarly, for the TMT_Part B, 31 (48%) 
participants had impaired executive functioning at three-months, reducing to 25 
(38%) participants with impaired executive functioning at six- months. However, the 
number of participants assessed as impaired on the MMSE rose slightly from 2 (2.7%) 
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participants at three months testing to 4 participants (5.9%) when tested at six months 
post ICU discharge (Table 2).  
 
Associations between Cognition, and Delirium and Duration of Mechanical 
Ventilation  
The presence of delirium in the ICU was significantly associated with TMT_Part A 
(processing speed) and B (executive functioning) scores at six-months in multivariate 
modelling (Table 3). However, delirium was not associated with variation in the 
TMT_Part A and B scores at three-months, or the RBANS total scores at either time 
points. Specifically, participants who experienced delirium in the ICU had a mean 
TMT_Part A score that was 7.86 seconds longer than those with no delirium (p=0.03), 
when holding age, education and Apache III levels fixed (Figure 2a). Further, 
participants who experienced delirium in the ICU had a mean TMT_Part_B score that 
was 24.0 seconds higher than those with no delirium (p=0.04), when holding age and 
education fixed (Figure 2b). 
Although not statistically significant, duration of mechanical ventilation 
demonstrated a trend of positive association with TMT_Part B scores (executive 
functioning) at six-months (Table 3). Delirium was not associated with the variation 
in TMT_Part B at three-months, nor for the TMT_Part A scores (processing speed) 
and RBANS total scores at either assessment time points. Specifically, the mean 
TMT_Part B score was 1.69 seconds longer (p=0.05) for those who received 
mechanical ventilation one day longer than the average duration (or, for example, 9.1 
seconds longer for those who received mechanical ventilation 5 days longer than the 
average duration), when holding age and education level fixed (Figure 2c). 
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Discussion 
The incidence of delirium in Australian general ICU patients and its association with 
patients’ cognition at post ICU discharge was assessed in this prospective cohort 
study. To our knowledge it is the first Australian study that has examined the 
relationship between delirium and long-term cognitive impairment. This study 
included a mixed cohort of medical, surgical and trauma ICU patients requiring 
mechanical ventilation thus broadening previous research beyond medical patients. 5  
We used well-known, psychometrically robust assessment tools for both delirium and 
cognitive impairment, and a design similar to a previously conducted study3 to enable 
international comparison. 
The incidence of delirium in this study was low, with one in five (19%) 
patients experiencing delirium of up to two days during their ICU stay. Whilst this is 
consistent with other Australian studies,6, 7, 11, 17 it is lower than that reported 
internationally, with Girard et al3 finding 84% of patients experience delirium for up 
to five days (50% ≥2 days; 25% ≥5 days) and others studies with 74% of ICU patients 
with respiratory failure or shock evaluated as delirious.4 Differences in the clinical 
characteristics of the patient populations including the  severity of illness and 
diagnoses between the current study and others may explain some of the disparity. 
Our participants had lower APACHE II scores indicating a lesser severity of illness 
that other studies3, 4 with APACHE II scores of 18 in our study versus 29 and 25 
respectively. In addition, our study had a mixed cohort whereas Girard et al’s study3  
participants were solely medical patients.  Our lower rates of delirium may also reflect 
the heterogeneity in international ICU nursing practices, with differences including a 
higher registered nurse/patient ratio in Australia than the USA (1:1 vs 1:2 or 1:3 
respectively). Although levels of registered nursing staff have been demonstrated to 
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influence adverse events such as hospital acquired pneumonia and unplanned 
extubation, links to delirium have not been investigated.37  
Consistent with previous research, the current study found that, whilst 
improvements in cognitive functioning occurred in the six-months post ICU 
discharge, many patients remained cognitively compromised.3, 4, 21, 22, 38 Notably, the 
rates of cognitive impairment found in the current study were much lower than that 
reported by others3, 4 and again, this disparity may be attributable to the older and 
sicker profile of their patients.  
When looking at the detection of cognitive impairment using the RBANS, the 
TMT_Parts A and B, and the MMSE, there were differences. When using the MMSE, 
only a minority were classified as impaired at three and six-months (1%; 3% 
respectively), which is in marked contrast to the rates reported when using the 
RBANS (41%; 24% respectively), and the TMT_Part A (32%; 26% respectively) and 
Part B (49%; 38% respectively). This distinction is an important finding as TMT_Part 
A and B have been found to be both sensitive and clinically significant in predicting 
functional independence in other cohorts.39, 40 Further, no one in the current study was 
assessed as severely impaired on the MMSE, with the lowest score at both assessment 
periods being 23, which is indicative of mild impairment. MMSE is a short, screening 
test that uses a small number of items in a restricted number of cognitive areas. The 
items used are simple in nature and are sensitive in detecting more severe or obvious 
cognitive problems. By contrast, RBANS and TMT_Part A and B have more items 
that range in difficulty levels. Consequently, for cognitive deficits caused by delirium, 
RBANS and TMT_Part A and B may be better in detecting more subtle deficits. We  
advocate the use of RBANS and TMT in future studies due to their greater sensitivity 
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in detecting cognitive impairment (globally and regarding information processing 
speed and executive functioning) in comparison to MMSE in this cohort. 
Whilst this study did not find an association between ICU delirium and long-
term global cognitive impairment using the RBANS, it did find that ICU delirium was 
positively associated with impaired information processing speed and executive 
functioning at six-months post-discharge. In addition, whilst just outside of statistical 
significance, there was a positive association between executive functioning speed 
and mechanical ventilation.  
Implications for practice and future research 
These findings add to the body of evidence 3,4, 19-22, 38, 41 of a relationship 
between ICU delirium and long-term cognitive impairment and support the need for 
interdisciplinary approaches to both screen for, and reduce delirium in ICU patients. 
Clinical care strategies that focus on modifiable factors including sensory impairment, 
immobilisation, metabolic derangement, pain and sedative management, emotional 
distress and sustained sleep deprivation are recommended.42,43  
ICU stay is clearly associated with psychological disorders,44  which in turn 
may have an effect on cognitive functions and visa versa. The potential complex 
relationship between delirium, cognitive impairment and psychological states such as 
anxiety, depression and post-traumatic stress syndrome is worthy of further study.   
Future well-resourced multi-centre studies assessing the potential predictive value of 
ICU delirium in terms of patient outcomes are needed to fully understand the impact 
on patients’ long-term cognition up-to and beyond the period of six-month and 
whether interventions to reduce the incidence and duration of delirium also impact on 
long term cognition. This study achieved a high retention of participants. Of those 
who were tested at the three-month period, 86% were retained at six-months and, 
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therefore, the feasibility of longitudinal cognitive testing of ICU patients is supported.  
In addition, understanding patient and family experiences of the impact of reduced 
cognition post ICU discharge is another area for investigation that would benefit from 
a qualitative research approach. Preliminary feasibility research supports further 
studies which include family members in the delivery of cognitive interventions 
within ICU to reduce delirium.45 Research into cognitive focused interventions across 
the spectrum of ICU, wards and post-hospital discharge are recommended. 
 Limitations 
The low incidence of delirium forced us to dichotomously classify ICU delirium, 
which may have reduced the study’s statistical power and prevented a stronger 
association between delirium and cognitive compromise from being found.19 Further, 
a CAM-ICU assessment was missing for 16% (n=24/148) of patients, which reduced the sample size and may also have contributed to reduced statistical power to detect differences. However, our sample size is comparable to that included in the Girard et al’s study at three- (n=76) and 12-month (n=52) assessment time-points. 3 Patients’ pre-existing cognitive impairment was not assessed (as is the case 
with any non-elective ICU populations), which limits understanding of any effect that 
this may have had on the observed impairments post-discharge. Data on any re-
hospitalization during the six-month prior to assessment was not collected and may 
have influenced participants’ health status. Finally, this was a single-site study and 
therefore limits the generalizability of findings beyond this site.  
 
Conclusions 
The relationship of delirium and long term cognitive impairment in general ICU 
patients was examined in this Australian study. ICU delirium was positively 
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associated with impaired information processing speed and executive functioning at 
six-months post-discharge for this cohort. Testing for cognitive impairment with 
RBANS and TMT should be considered due to its greater sensitivity in comparison to 
the MMSE. In light of the growing number of patients surviving ICU each year, 
strategies to reduce and prevent delirium and potentially improve long-term cognitive 
function are imperative.  
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Figure 1 Participant flow through the study 
*Three participants were unable to complete three month testing (deemed lost to follow-up), but 
were able to complete the six month testing; n=76 completed testing at both three and six months. 
• Withdrawn (n=9) 
• Lost to follow-up (n=3) 
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• Significant mental health 
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• Other reasons (n=141) 
 
 6-MONTH FOLLOW-UP 
 Completed outcome measures (n=79)* 
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• Declined to 
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Table 1 Participant and clinical characteristics  
Characteristic Cohort, n=91 
Age (years)a 57 (43-65) 
Sex (male) 63 (69%) 
Education:  
12 years of education or less 27 (36%) 
Certificate/diploma 27 (36%) 
University degree or higher 21 (28%) 
Admission diagnosis:  
Cardiac surgical 19 (21%) 
Cardiac non-surgical 20 (22%) 
Surgical  16 (18%) 
Medical 18 (20%) 
Trauma 
        Other 
15 (16%) 
3 (3%) 
APACHE II scoreb,c 18.1 (5.97) 
APACHE III scoreb,d 56.5 (22.4) 
Length of stay in ICU (days)a 4.3 (2.1-7.9) 
Length of stay in hospital (days)a 17.7 (12.1-27.1) 
Propofol dose (mg)a 3,820 (1,500-9,190) 
Benzodiazepine dose (mg lorazepam eq.)a 15 (0-90) 
Opioid dose (mg fentanyl eq.)a 3.7 (1.5-8.8) 
Days of mechanical ventilation (days)a 2.2 (1.0-5.1) 
Delirium in ICU (days):  
zero 62 (82%)  
 25 
one 9 (12%) 
two 
 
5 (7%) 
n (%) shown unless otherwise indicated. Continuous variables reported as mean and standard deviation (SD) if 
normally distributed, or as median and 25th/75th percentiles otherwise.  
Frequencies and proportions may not add up to n=91 and 100% due to missing data or rounding 
APACHE Acute Physiology and Chronic Health Evaluation, ICU Intensive Care Unit, mg Milligram, eq. Equivalent 
amedian (25th/75th) 
bmean (SD) 
cAPACHE II scores range 0 – 71 with higher scores indicating more severe disease 
dAPACHE III scores range 0-299 with higher scores indicating more severe disease  
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Table 2 Cognitive outcomes at three and six months  
Measure 3 months n=88 6 months n=79 
RBANS: 
  
list learningb 25.1 (4.9) 26.6 (4.7) 
story memorya 14.0 (11.0-16.0) 17.0 (13.0-19.0) 
figure drawinga 20.0 (19.0-20.0) 20.0 (19.0-20.0) 
line orientationa 19.0 (17.0-20.0) 19.0 (17.0-20.0) 
picture naminga 10.0 (10.0-10.0) 10.0 (10.0-10.0) 
semantic fluencyb 19.8 (4.7) 20.3 (4.2) 
digit spana 10.0 (8.0-12.0) 10.0 (8.0-12.0) 
codingb 39.5 (11.3) 41.3 (10.1) 
list recallb 4.56 (2.6) 5.49 (2.5) 
list recognitiona 19.0 (18.0-20.0) 20.0 (19.0-20.0) 
story recalla 8.0 (4.5-10.0) 9.0 (7.0-11.0) 
figure recalla 15.0 (12.0-18.0) 17.0 (14.0-19.0) 
Immediate Memory Scale Scoreb 84.8 (16.4) 93.2 (15.9) 
Visuospatial/Constructional Scale Scorea 112 (102-126) 121 (102-126) 
Language Scale Scorea 98.5 (90.0-104) 99.0 (92.0-105) 
Attention Scale Scoreb 88.7 (15.7) 94.1 (13.7) 
Delayed Memory Scale Scoreb 93.7 (16.4) 100 (14.2) 
Total Scale Scoreb 93.3 (13.5) 99.8 (12.7) 
RBANS impairmentc,d 36/88(40.9%) 19/79 (24.1%)  
TMT_Part A impairmentc,e 24/75 (32.0%) 18/68 (26.5%) 
TMT_Part B impairmentc,f 36/73 (49.3%) 26/68 (38.2%) 
MMSE impairmentc,g 2/75 (2.7%) 4/68 (5.9%)  
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RBANS impairment – participants tested at each time point 
No impairment 52 (59.1%) 60 (75.9%) 
Mild/moderate impairment 14 (15.9%) 11 (13.9%) 
Severe impairment 11 (12.5%) 1 (1.3%) 
One of the five RBANS domains 1.5 SDs below the mean 1 (12.5%) 7 (8.9%) 
RBANS impairment – participants tested at both time point (n=76) 
No impairment 49 (64.5%) 59 (77.6%) 
Mild/moderate impairment 10 (13.2%) 10 (13.2%) 
Severe impairment 10 (13.2%) 1 (1.3%) 
One of the five RBANS domains 1.5 SDs below the mean 7 (9.2%) 6 (7.9%) 
Continuous variables reported as mean and standard deviation (SD) if normally distributed, or as median and 
25th/75th percentiles otherwise 
RBANS Repeatable Battery for the Assessment of Neuropsychological Status, MMSE Mini Mental State 
Examination, TMT= Trail Making Test, SD Standard Deviation 
amedian (25th/75th) 
bmean (SD) 
cn (%) 
dincludes mild to moderate, severe, and one domain score 1.5 standard deviations below the mean 
ecompletion time 40 seconds or longer 
fcompletion time 92 seconds or longer 
gscore of 26 or below 
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Table 3 Associations of ICU exposures (positive assessment of delirium; number of days of 
mechanical ventilation), with long-term cognitive outcomes (at three and six months) 
 Multivariable regression results 
Predictor Point estimate 95% CI p value 
RBANS (total score)    
Delirium (yes/no)    
  Association with 3 month outcomea 1.88 -6.14 to 9.90 0.641 
  Association with 6 month outcomea -2.23 -10.0 to 5.57 0.569 
Ventilator days    
  Association with 3 month outcomeb -0.36 -1.12 to 0.41 0.353 
  Association with 6 month outcomec 0.27 -0.71 to 1.24 0.586 
    
TMT_Part A (seconds)    
Delirium (yes/no)    
  Association with 3 month outcomed 0.86 -3.32 to 6.44 0.713 
  Association with 6 month outcomea 7.86 0.68 to 17.9 0.030 
Ventilator days    
  Association with 3 month outcomed 0.02 -0.38 to 0.43 0.918 
  Association with 6 month outcomea 0.27 -0.28 to 0.83 0.331 
    
TMT_Part B (seconds)    
Delirium (yes/no)    
  Association with 3 month outcomea 17.9 -8.02 to  58.7 0.203 
  Association with 6 month outcomea 24.0 0.92 to 59.5 0.040 
Ventilator days    
  Association with 3 month outcomea 1.64 3.70 to -0.35 0.106 
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  Association with 6 month outcomea 1.69 0.00 to  3.45 0.050 
The point estimate indicates the change in scores on the respective cognitive tests, back-transformed where necessary 
aadjusted for age and education 
badjusted for age, education, and sex 
cadjusted for age, education, sex and benzodiazepine 
dadjusted for age, education and APACHE III 
ICU Intensive Care Unit, CI Confidence Interval, RBANS Total score of the Repeatable Battery for the Assessment of 
Neuropsychological Status, TMT Trail Making Test (seconds) 
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Figure 2 Relationship between delirium, cognition and duration of mechanical 
ventilation  
 
 
Figure 2a Relationship between positive assessment of delirium in the ICU and mean TMT_Part A 
scores at six months 
p=0.03, TMT_Trail Making Test, ICU Intensive Care Unit, CI Confidence Intervals. 
 
 
Figure 2b Relationship between positive assessment of delirium in the ICU and mean TMT_Part B 
scores at six months 
p=0.04, TMT_Trail Making Test, ICU Intensive Care Unit, CI Confidence Intervals. 
 
 
Figure 2c Relationship between duration of mechanical ventilation in the ICU and mean TMT_Part 
B scores at six months 
p=0.05, TMT_Trail Making Test, mech. mechanical, ICU Intensive Care Unit, CI Confidence Intervals 
 
 
